Biosorb gelling fiber is a wound dressing, which forms a gel when it comes into contact with an exuding wound.

The company has also received CE mark approval for the Biosorb gelling fiber dressing. It is expected to be available in Europe in the coming months.

The new dressing has been designed to be used for different exuding wounds such as leg ulcers, pressure ulcers and diabetic foot ulcers.

It can also be used for surgical wounds that exude fluid, partial thickness burns, traumatic and oncology wounds.

Biosorb features carboxymethylcellulose (CMC), which enables the dressing to absorb many times its own weight in fluid to protect the wound edge and surrounding skin.

The dressing is currently available in the non-silver format (non-antimicrobial), while silver version (anti-microbial) is expected to be launched in early next year.

Acelity president and CEO Joe Woody said: “The addition of gelling fiber delivers on an important component of our business strategy in that Acelity now has a complete range of advanced wound dressings that will address a full spectrum of patient needs.

“These dressings, combined with our negative pressure wound technologies form the most comprehensive wound care portfolio offering clinicians around the world healing solutions no matter the acuity or care setting.”

Based in San Antonio of Texas, Acelity markets its wound care and regenerative medicine products in around 80 countries.